src: care.diabetesjournals.org
Video Book:Anti-diabetic drugs
Anti-diabetic drugs
- Anti-diabetic drugs
- Albiglutide
- Amylin
- Anti-diabetic medication
- Dapagliflozin
- Exenatide
- Glucagon-like peptide-1
- Glucagon-like peptide-1 agonist
- GSK716155
- Imeglimin
- Liraglutide
- Lixisenatide
- Pramlintide
- Remogliflozin etabonate
- Sergliflozin etabonate
- Sitagliptin
- Sorbinil
- Taspoglutide
- Vildagliptin
- Alpha-glucosidase inhibitors
- Acarbose
- Acarviosin
- Alpha-glucosidase inhibitor
- Miglitol
- Voglibose
- Biguanides
- Biguanide
- Bisbiguanide
- Buformin
- Chlorhexidine
- Metformin
- Phenformin
- Dipeptidyl peptidase-4 inhibitors
- Dipeptidyl peptidase-4 inhibitor
- Alogliptin
- Development of dipeptidyl peptidase-4 inhibitors
- Gemigliptin
- Linagliptin
- Saxagliptin
- Insulin therapies
- Artificial pancreas
- Basal
- Basal rate
- Blood glucose monitoring
- Chronic Somogyi rebound
- Conventional insulinotherapy
- Dawn phenomenon
- Diabetes control and complications trial
- Diabetes management software
- Fluorescent glucose biosensor
- Glucagon rescue
- Glucommander
- Glucose clamp technique
- Humulin
- Hyperinsulinemic hypoglycemia
- Infusion set
- Inhalable insulin
- Injection port
- Insulin
- Insulin analog
- Insulin aspart
- Insulin degludec
- Insulin detemir
- Insulin glargine
- Insulin glulisine
- Insulin lispro
- Insulin pen
- Insulin port
- Insulin pump
- Insulin shock therapy
- Insulin therapy
- Intensive insulinotherapy
- Minimed Paradigm
- NPH insulin
- Pulsatile insulin
- Ultralente
- Untethered regimen
- Meglitinides
- Meglitinide
- Mitiglinide
- Nateglinide
- Repaglinide
- Sulfonylureas
- Sulfonylurea
- Acetohexamide
- Carbutamide
- Chlorpropamide
- Glibenclamide
- Glibornuride
- Glicaramide
- Gliclazide
- Glimepiride
- Glipizide
- Gliquidone
- Glisoxepide
- Glyclopyramide
- Metahexamide
- Tolazamide
- Tolbutamide
- Torasemide
- Thiazolidinediones
- Thiazolidinedione
- Ciglitazone
- Darglitazone
- Englitazone
- Netoglitazone
- Pioglitazone
- Rivoglitazone
- Rosiglitazone
- Troglitazone
Source of article : Wikipedia
0 Comments